Brain and Central Nervous System Tumors
Showing NaN - NaN of 58
Brain and CNS Tumors Trial in United States (BGB 324 (before surgery), BGB 324 (after surgery))
Active, not recruiting
- Brain and Central Nervous System Tumors
- BGB 324 (before surgery)
- BGB 324 (after surgery)
-
Birmingham, Alabama
- +5 more
Dec 1, 2022
Brain and CNS Tumors, Neurotoxicity Trial in United States (temozolomide, 3-dimensional conformal radiation therapy,
Active, not recruiting
- Brain and Central Nervous System Tumors
- Neurotoxicity
- temozolomide
- +2 more
-
Birmingham, Alabama
- +167 more
Aug 9, 2022
Brain and CNS Tumors Trial in Worldwide (concomitant temozolomide (TMZ), radiotherapy, procarbazine)
Recruiting
- Brain and Central Nervous System Tumors
- concomitant temozolomide (TMZ)
- +5 more
-
Birmingham, Alabama
- +277 more
Mar 22, 2022
Brain and CNS Tumors, Cognitive/Functional Effects, Fatigue Trial in United States (modafinil, )
Completed
- Brain and Central Nervous System Tumors
- +4 more
- modafinil
- placebo
-
Birmingham, Alabama
- +59 more
Jul 20, 2021
Brain and CNS Tumors Trial in Canada, United States (tamoxifen citrate, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- tamoxifen citrate
- radiation therapy
-
Birmingham, Alabama
- +256 more
Oct 21, 2020
Brain and CNS Tumors Trial in Canada, United States (carmustine, radiation therapy, stereotactic radiosurgery)
Completed
- Brain and Central Nervous System Tumors
- carmustine
- +2 more
-
Birmingham, Alabama
- +235 more
Oct 21, 2020
Brain and CNS Tumors Trial in United States (drug, other, radiation)
Completed
- Brain and Central Nervous System Tumors
- hydroxychloroquine
- +3 more
-
Birmingham, Alabama
- +8 more
Jun 19, 2019
Brain and CNS Tumors Trial in United States (temozolomide, 3'-deoxy-3'-[18F]fluorothymidine, pharmacological study)
Completed
- Brain and Central Nervous System Tumors
- temozolomide
- +3 more
-
Birmingham, Alabama
- +6 more
May 21, 2019
Brain and CNS Tumors Trial in United States (terameprocol, pharmacological study)
Completed
- Brain and Central Nervous System Tumors
- terameprocol
- pharmacological study
-
Birmingham, Alabama
- +8 more
Mar 1, 2019
DevelopingBlood Clot in Undergoing Cancer Treatment for Newly
Completed
- Brain and Central Nervous System Tumors
- Thromboembolism
- laboratory biomarker analysis
- +2 more
-
Birmingham, Alabama
- +8 more
Jun 26, 2018
Brain and CNS Tumors Trial in United States (drug, genetic, other, procedure, radiation)
Completed
- Brain and Central Nervous System Tumors
- temozolomide
- +13 more
-
Birmingham, Alabama
- +10 more
Jun 25, 2018
Brain and CNS Tumors Trial in United Kingdom (drug, genetic, other, procedure)
Completed
- Brain and Central Nervous System Tumors
- olaparib
- +8 more
-
Bristol, England, United Kingdom
- +6 more
Feb 1, 2018
Brain and CNS Tumors Trial in United States (iodine I 131 mAb TNT-1/B)
Completed
- Brain and Central Nervous System Tumors
- iodine I 131 monoclonal antibody TNT-1/B
-
Birmingham, Alabama
- +3 more
Feb 17, 2016
Brain and CNS Tumors Trial in Canada, United States (carmustine, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- carmustine
- radiation therapy
-
Birmingham, Alabama
- +236 more
Nov 14, 2015
Brain and CNS Tumors, Neuroblastoma, Sarcoma Trial in Worldwide (vinorelbine tartrate)
Completed
- Brain and Central Nervous System Tumors
- +2 more
- vinorelbine tartrate
-
Birmingham, Alabama
- +227 more
Jul 25, 2014
Brain and CNS Tumors Trial in Worldwide (drug, procedure, radiation)
Completed
- Brain and Central Nervous System Tumors
- temozolomide
- +2 more
-
Birmingham, Alabama
- +229 more
Feb 19, 2014
Brain and CNS Tumors, Child Solid Tumor Trial in Canada, United States (irinotecan HCl, temozolomide, vincristine sulfate)
Completed
- Brain and Central Nervous System Tumors
- Unspecified Childhood Solid Tumor, Protocol Specific
- irinotecan hydrochloride
- +2 more
-
Birmingham, Alabama
- +17 more
Feb 18, 2014
Brain and CNS Tumors, Neurofibromatosis Type 1 Trial in Canada, United States (carboplatin, vinblastine sulfate)
Completed
- Brain and Central Nervous System Tumors
- Neurofibromatosis Type 1
- carboplatin
- vinblastine sulfate
-
Birmingham, Alabama
- +20 more
Feb 11, 2014
Brain and CNS Tumors, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (imetelstat sodium, laboratory
Completed
- Brain and Central Nervous System Tumors
- +4 more
- imetelstat sodium
- +2 more
-
Birmingham, Alabama
- +22 more
Jan 29, 2014
Brain and CNS Tumors Trial in Birmingham (drug, other, radiation)
Terminated
- Brain and Central Nervous System Tumors
- boron phenylalanine
- +3 more
-
Birmingham, England, United Kingdom
- +1 more
Oct 7, 2013
Observing Young Ependymoma Undergoing Standard Combination
Active, not recruiting
- Brain and Central Nervous System Tumors
- +3 more
- carboplatin
- +9 more
-
Birmingham, England, United Kingdom
- +9 more
Sep 19, 2013
Brain and CNS Tumors Trial in Ireland, United Kingdom (drug, genetic, other, radiation)
Unknown status
- Brain and Central Nervous System Tumors
- erlotinib hydrochloride
- +5 more
-
Dublin, Ireland
- +20 more
Sep 19, 2013
Quality of Life in Undergone Previous Treatment for Primitive
Unknown status
- Brain and Central Nervous System Tumors
- +3 more
- cognitive assessment
- +2 more
-
Dublin, Ireland
- +20 more
Sep 19, 2013
Brain and CNS Tumors, Chordoma, Kidney Cancer Trial in Ireland, United Kingdom (polyvinylpyrrolidone-sodium hyaluronate gel)
Unknown status
- Brain and Central Nervous System Tumors
- +9 more
- polyvinylpyrrolidone-sodium hyaluronate gel
-
Dublin, Ireland
- +20 more
Sep 19, 2013
Brain and CNS Tumors Trial in Ireland, United Kingdom (methotrexate, adjuvant therapy)
Unknown status
- Brain and Central Nervous System Tumors
- methotrexate
- adjuvant therapy
-
Dublin, Ireland
- +20 more
Sep 16, 2013